
Vitruvian Partners is a global private equity firm focusing on growth buyout and growth capital investments in middle-market companies. The firm invests between €40m–€600m+ in companies typically valued between €75m–€4bn+.
Average disclosed round size is $150.7M (across 53 rounds with reported amounts).
Portfolio
43
Fund Size
$8.1B
Top Stage
Growth
Last 12 Mo
4
Team
AT
Amit Tiwari
Managing Director
BJ
Ben Johnson
Partner
DN
David Nahama
Senior Partner
AL
Alexander Limoges Friend
Associate Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
65 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series F | $350M | Jun 2026 | |
| Series C | $350M | Jan 2026 | |
| Growth | $100M | Jan 2026 | |
| Seed | $3.5M | Dec 2025 | |
| Unknown | — | Dec 2025 | |
| Unknown | $400M | Nov 2025 | |
| Unknown | $188M | Sep 2025 | |
| Series G | $359M | Jun 2025 | |
| Growth | $190M | May 2025 | |
| Series G | $230M | May 2025 | |
| Series D | $150M | Apr 2025 | |
| Series A | $20M | Jan 2025 | |
| Unknown | $200M | Jan 2025 | |
| Unknown | $92M | Jan 2025 | |
| Growth | $188M | Jan 2025 | |
| Growth | $52M | Jan 2024 | |
| Series B | $8.8M | Nov 2023 | |
| Series C | $200M | Jun 2022 | |
| Series C | $100M | Jun 2022 | |
| Growth | $800M | Mar 2022 | |
| Growth | $227M | Jan 2022 | |
| AAda Health | Series B | $120M | Jan 2022 |
| Seed | $1B | Jan 2022 | |
| Series E | $100M | Jan 2022 | |
| Series B | $30M | Jan 2022 |
Page 1 of 3
Top Co-Investors
Accel7 shared
Balderton Capital6 shared
Condé Nast6 shared
Index Ventures6 shared
Mutschler Ventures6 shared
The Goldman Sachs Group, Inc.5 shared
Eurazeo5 shared
Bpifrance4 shared
Leaps by Bayer4 shared
Samsung Catalyst Fund4 shared
EDBI3 shared
Citi Ventures3 shared
Endeavor3 shared
Vaultier73 shared
Korelya Capital3 shared
Idinvest Partners3 shared
Lead Edge Capital3 shared
Advent International3 shared
J.P. Morgan3 shared
Last updated: 20 October 2026